Xvivo Perfusion AB (XVIVO) — Capital Reinvestment Ratio
Xvivo Perfusion AB (XVIVO) has a Capital Reinvestment Ratio of 0.22x as of June 2026, meaning it reinvests 0% of its operating cash flow (Skr63.49 Million) in capital expenditures (Skr13.80 Million). Check XVIVO tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xvivo Perfusion AB Capital Reinvestment Ratio (2011–2025)
This chart tracks Xvivo Perfusion AB's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see XVIVO cash flow metrics.
Annual Capital Reinvestment Ratio for Xvivo Perfusion AB (2011–2025)
Year-by-year Capital Reinvestment Ratio for Xvivo Perfusion AB from 2011 to 2025. See cash generation quality of Xvivo Perfusion AB to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr101.07 Million | Skr101.07 Million | ▼ -42.4% |
| 2024 | 1.74x | Skr111.29 Million | Skr193.15 Million | ▲ +86.8% |
| 2023 | 0.93x | Skr46.29 Million | Skr43.02 Million | ▼ -80.2% |
| 2022 | 4.70x | Skr27.86 Million | Skr130.95 Million | ▲ +65.7% |
| 2019 | 2.84x | Skr29.50 Million | Skr83.69 Million | ▲ +22.5% |
| 2018 | 2.32x | Skr23.63 Million | Skr54.71 Million | ▲ +47.1% |
| 2017 | 1.57x | Skr22.19 Million | Skr34.93 Million | ▼ -3.7% |
| 2016 | 1.63x | Skr12.55 Million | Skr20.51 Million | ▲ +6.1% |
| 2015 | 1.54x | Skr8.58 Million | Skr13.21 Million | ▲ +64.7% |
| 2013 | 0.94x | Skr13.46 Million | Skr12.59 Million | ▼ -47.3% |
| 2012 | 1.77x | Skr1.67 Million | Skr2.96 Million | ▲ +96549.9% |
| 2011 | 0.00x | Skr14.17 Million | Skr26.00K | — |